← All stories
Markets
Shield Therapeutics (LSE:STX) slides despite a firm update: what is the market pricing that the release did not say?
Highlights Shield Therapeutics shares fell sharply in a week that also produced outsized AIM gainers The decline followed a trading update that on its face appeared constructive Junior market pricing reflects funding runway, expectations an…
Covered by 1 outlet
All coverage · 1 article